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Abstract 
 
We have previously demonstrated that a single exposure to cocaine during adolescence causes several 
behavioural and neurobiological changes, highlighting the unique vulnerability of this period of life. The 
purpose of our work was to investigate whether a single exposure to cocaine during brain development is 
sufficient to shape a negative emotional state in adolescent rats. 
A single injection of cocaine during adolescence followed by measurement of sucrose consumption, a 
measure of anhedonia, identifies two separate groups of rats, i.e. anhedonic (AN) and non anhedonic 
(NON-AN) rats. AN rats show reduced ability to synthesize, traffic and translate the neurotrophin at 
synaptic level, reduced activation of hippocampal BDNF signaling, reduced BDNF plasma levels and a 
steep rise of corticosterone secretion. Conversely, NON-AN rats exhibit reduced trafficking of BDNF while 
up-regulating hippocampal BDNF synthesis and stabilizing its downstream signaling with no changes of 
BDNF and corticosterone plasma levels. Adult rats showed no signs of anhedonia, an increase of BDNF 
both in hippocampus and plasma and decreased levels of corticosterone.  
In conclusion, our findings reveal a complex central and peripheral dysregulation of BDNF-related 
mechanisms that instead are preserved in NON-AN rats, suggesting that BDNF modulation dictates 
behavioural vulnerability vs. resiliency to cocaine-induced anhedonia, a profile uniquely restricted to 
adolescent rats. 
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1. Introduction 
 
It is well established that adolescence is a period of unique susceptibility to drug abuse (Andersen 
2003; Ernst et al. 2009; Spear 2000; Kelley 2004; Casey et al. 2008). We and others have contributed to 
demonstrate that interfering with such vulnerable period through exposure to cocaine may alter the 
correct trajectories of brain development causing functional consequence through behavioural, molecular 
and structural changes (Giannotti et al. 2014; Caffino et al. 2015a; Caffino et al. 2015b; Caffino et al. 
2017b; Caffino et al. 2018; Caputi et al. 2019; Caffino et al. 2017a; DePoy et al. 2014). In addition, we 
have shown that also a single exposure to cocaine during this vulnerable period may be functionally 
relevant. In fact, we have recently demonstrated that a single injection of the psychostimulant during 
brain development is sufficient to disrupt actin dynamics (Caffino et al. 2017b) and to alter dendritic 
spine morphology (Caffino et al. 2018). In antoher manuscript, we found that a single exposure to 
cocaine reduced the expression of the trophic factor FGF-2 when measured 7 days after the single 
injection (Giannotti et al. 2015), suggesting a long-lasting effect on a molecule implicated in depression 
(Evans et al. 2004; Riva et al. 2005) and whose expression has been shown to be up-regulated by 
antidepressant treatments in rodents (Maragnoli et al. 2004; Bachis et al. 2008). The latter finding is 
indeed interesting since it raises the intriguing possibility, yet unexplored, that a single injection of 
cocaine during a sensitive period of brain development may be sufficient to cause a negative emotional 
state in rodents.  
Thus, our major aims were 1) to investigate whether a single injection of cocaine during 
adolescence is sufficient to cause negative emotional state through the evaluation of one of its core 
symptoms, i.e. anhedonia, and 2) to find a putative, underlying molecular mechanism. To this end, we 
have focused our attention on Brain Derived Neurotrophic Factor (BDNF), since this neurotrophin has 
been implicated in the dysregulation of emotional states (Fumagalli et al. 2007; Bjorkholm & Monteggia 
2016), cognition (Kesslak et al. 1998; Bekinschtein et al. 2014; Leo et al. 2018) as well as in the action 
of psychostimulants (Fumagalli et al. 2013; Li & Wolf 2015; Verheij et al. 2016; Leo et al. 2018). Further, 
evidence exists showing that the modulation of hippocampal BDNF directly controls anhedonia (Taliaz et 
al. 2010; Dong et al. 2018). The hippocampus is an important part of the limbic system involved in the 
regulation of emotion and cognition. Although it has not been extensively studied with respect to drug 
abuse, it is integrated anatomically and functionally into the addiction network and it interacts with 
addiction-related areas (Castilla-Ortega et al. 2016): for these reasons, neuroplastic changes in this brain 
region may be critical for the effects of drugs of abuse. 
We thus have investigated the effect of a single injection of cocaine during adolescence in rats 
exposed to the sucrose preference test. Accordingly, adolescent rats at post-natal day (PND) 35 were 
first exposed to a single cocaine injection or saline and, a week later (i.e. at PND42), the same rats were 
subjected to the sucrose preference test to measure anhedonia. Behavioural measurements were 
accompanied by in-depth evaluation of BDNF levels both in the brain (hippocampus) and plasma. Further, 
levels of corticosterone in the plasma and hippocampal glucocorticoid receptor expression were 
measured, as activation of hypothalamic-pituitary adrenal (HPA) axis is strictly correlated to negative 
emotional states. In order to verify that changes set in motion by a single exposure to cocaine during 
brain development could be specific of adolescence or, rather, common to adulthood, we exposed adult 
rats to the same experimental paradigm, performing the same behavioural and molecular evaluations in 
these rats. 
 
 
2. Material and Methods 
 
2.1 Experimental procedures 
Adolescent and adult Sprague Dawley male rats used in this study were obtained from Charles River 
(Calco, Italy) and housed under standard conditions of temperature and humidity under artificial light 
(from 07:00 to 19:00 hours). A maximum of two male siblings was taken from each litter in order to 
reduce “litter effects” (Chapman & Stern 1978).  
Rats were shipped to us at post-natal day 28. They were habituated in the facility before starting the 
cocaine exposure for one week. In details, rats were left undisturbed for two days and then they were 
handled for 5 days before the injection: such manipulation was performed in order to avoid any potential 
bias due to stress-related effects. 
Experiment 1. Forty rats were exposed to a single intraperitoneal injection (i.p.) of saline (n = 
12) or cocaine  (n = 28) (20 mg/kg) at postnatal day 35 (PND 35) and 7 days later, i.e. at PND 42, 
during a period that roughly approximates adolescence in humans (Collins & Izenwasser 2004; 
Maldonado & Kirstein 2005), animals were exposed at the sucrose preference test and three hours later 
they were sacrificed. A total of 2 cocaine- and 2 saline-exposed animals were removed from the study 
because they did not respond properly to the sucrose preference test. At the scheduled time of sacrifice, 
the whole hippocampus (Hip) from 7 saline- and 20 cocaine-exposed rats was grossly dissected from 2-
mm thick slices, frozen on dry ice and stored at -80°C to perform the molecular analysis; whereas the 
whole brain from 3 saline- and 6 cocaine-exposed rats was removed and post-fixed in PFA 4% for 24 
hours to perform in situ hybridization. 
Experiment 2. To investigate whether the effects of a single cocaine administration were different 
between adolescent and adult animals, we incorporated 22 adult rats that were treated with saline or 
cocaine i.p. (20 mg/kg) at postnatal day 70 and then, at PND 77, they were exposed at the sucrose 
preference test and three hours later sacrificed. A total of 3 cocaine- and 1 saline-treated rats were 
removed from the study because they did not respond properly to the sucrose preference test. At the 
scheduled time of sacrifice, the whole hippocampus (Hip) was grossly dissected from 2-mm thick slices, 
frozen on dry ice and stored at -80°C.  
 
Procedures involving animals were conducted at the Department of Pharmacological and 
Biomolecular Sciences, which adheres to the principles set out in the following laws, regulations, and 
policies governing the care and use of laboratory animals: Italian Governing Law (D.lgs 26/2014; 
Authorization n.19/2008-A issued March 6, 2008 by Ministry of Health); the NIH Guide for the Care and 
Use of Laboratory Animals (2011 edition) and EU directives and guidelines (EEC Council Directive 
2010/63/UE). All efforts were made to minimize animal suffering and to keep the lowest number of 
animals used. The experiments have been reported in compliance with the ARRIVE guidelines. 
 
2.2 Sucrose preference test 
The sucrose preference test (SPT) was used to assess anhedonia at PND 42 or at PND 77 in rats exposed 
to a single injection of cocaine at PND 35 or at PND70, respectively. Rats were habituated to 2 water 
bottles for 5 days and exposed to water deprivation overnight (19:00-9:00 hours) the night before the 
test day. During a 1-hour session (9:00-10:00 hours), rats were housed individually and given access to 
two bottles, positioned side-by-side at the rear of the cage, one containing regular water and the other 
containing 1% sucrose solution diluted in tap water. At the end of the test, all animals are returned to 
group housing with food and water ad libitum. 
The solution has been allowed to warm to room temperature (22 °C ± 1 °C) 1 h before 
introducing to animals.	 Before and after consumption, fluid was measured by weighing each bottle. 
Sucrose preference was calculated as sucrose intake(g)/total fluid (sucrose + water) intake (g) X 100. 
Rats showing a sucrose/(total fluid intake) ratio above 0.5 were defined as NON-anehdonic, and those 
showing a lower sucrose/(total fluid intake) ratio were defined as anhedonic. This criterion was based on 
the fact that the averaged ratio of the control animals group showed a sucrose/(total fluid intake) ratio 
above 0.5 (Strekalova et al. 2006). 
 
2.3 RNA Preparation and Real-Time Polymerase Chain Reaction 
RNA measures were taken in the same animals as the protein measures. Total RNA was isolated 
by single step guanidinium isothiocyanate/phenol extraction using PureZol RNA isolation reagent (Bio-Rad 
Laboratories, Segrate, Milan, Italy) according to the manufacturer’s instructions and quantified by 
spectrophotometric analysis. Following total RNA extraction, the samples were processed for real-time 
reverse transcription polymerase chain reaction (real time RT-PCR) to assess mRNA levels, as previously 
described (Caffino et al. 2019). 
The primer efficiencies were experimentally set up for each couple of primers. Probe and primers for and 
Bdnf exon VI were purchased from Life Technologies (Bdnf exon IV: ID Rn01484927_m1 and Bdnf exon 
VI: ID Rn01484928_m1). Primers and probe for total Bdnf and 36B4 were purchased from Eurofins 
MWG-Operon. Their sequences are shown below: 
- total Bdnf: forward primer 5’-AAGTCTGCATTACATTCCTCGA-3’, reverse primer 5’- 
GTTTTCTGAAAGAGGGACAGTTTAT-3’, probe 5’-TGTGGTTTGTTGCCGTTGCCAAG-3’; 
- Bdnf exon I: forward primer 5′-GGGAGACGAGATTTTAAGACACTG-3′, reverse primer 5′-
GTCATCACTCTTCTCACCTGG-3′, probe 5′-TTGTGGCTTTGCTGTCCTGGAGA-3′; 
- 36B4: forward primer 5’-TTCCCACTGGCTGAAAAGGT-3’, reverse primer 5’- CGCAGCCGCAAATGC-3’, 
probe 5’-AAGGCCTTCCTGGCCGATCCATC-3’. 
 
2.4 Riboprobes preparation for in situ hybridization  
Digoxigenin (DIG)-labeled riboprobes detecting total Bdnf and Bdnf exon VI transcripts were 
generated from PCR templates adapted with SP6 and T7 RNA polymerase sites (Tornese et al. 2019). 
Riboprobes were transcribed using a DIG RNA Labeling Kit (Thermo Scientific, Monza, MB, Italy), 
according to the manufacturer’s instructions. Specifically, the 20 µl transcription mixture included 200 ng 
of template purified cDNA, 1x Transcription Buffer, 0.5 mM ATP, 0.5 mM CTP, 0.5 mM GTP, 0.17 mM UTP, 
0.33 mM DIG-UTP (Life Technologies, Monza, MB, Italy), and 40 U of either T7 or SP6 RNA polymerase 
(Russo et al. 2013). The reaction was incubated for 2 h at 37° C and stopped by adding 0.5 M EDTA. The 
riboprobes were then purified in NucAwayTM spin columns (Ambion, Monza, MB, Italy) and quantified 
with Nanodrop 1000 (Thermo Scientific, Monza, MB, Italy). 
 
2.5 In situ hybridization 
After sacrifice, brains were fixed in the 4% PFA solution for 24 h and subsequently placed in 30% 
sucrose before sectioning. Coronal slices (40 µm) were prepared and stored in cryo-protectant sectioning 
buffer (30% ethylene glycol, 30% glycerol and 0.05M phosphate buffer) at -20°C until further processing. 
In situ hybridization experiments on brain slices were carried out under RNAse-free conditions. In 
situ hybridization was developed using the Vectastain® Elite ABC-Peroxidase Staining Kit (Vector 
Laboratories, Segrate, MI, Italy) (La Via et al. 2013; Russo et al. 2013). Free-floating sections were post-
fixated over-night in 4% PFA at 4°C. Following 3 washes in 0.1 Tween 20 in 1x PBS (PBST) at RT for 5 
min the slices were quickly washed in H2O, permeabilized with 2.3% sodium meta-periodate (Sigma-
Aldrich, Milano, Italy) in H2O at RT for 5 min, and then quickly washed in H2O. After these steps, the 
sections were incubated in 1% sodium borohydride (Sigma-Aldrich, Milano, Italy) in 0.1 M Tris-HCl buffer 
pH 7.5 at RT for 10 min, and then washed twice in PBST at RT for 3 min. The slices were digested with 8 
µg/ml proteinase K (Sigma-Aldrich, Milano, Italy) in PBST at RT for 20 min and washed twice in PBST at 
RT for 5 min. After digestion, the tissue slices were fixed in 4% PFA at RT for 5 min and washed three 
times in PBST at RT for 10 min. Slices were then incubated ON at 55° C in the hybridization solution 
containing 20 mM Tris-HCl (pH7.5) (Sigma-Aldrich, Milano, Italy), 1 mM EDTA (Gibco, Monza, MB, Italy), 
1x Denhardt’s solution (Invitrogen, Monza, MB, Italy), 300 mM NaCl, 100 mM DTT (Fluka, Milano, Italy), 
0.5 mg/ml salmon sperm DNA (Gibco, Monza, MB, Italy), 0.5 mg/ml polyadenylic acid (Sigma-Aldrich, 
Milano, Italy), and 50% formamide (Sigma-Aldrich, Milano, Italy), supplemented with 10% dextransulfate 
and 100 ng/ml DIG-labeled riboprobes. The next day, the slices were washed twice in 2x saline sodium 
citrate, 0.1 % Tween 20 (SSCT), and 50% deionized formamide at 55° C for 30 min; for 20 min in 2x 
SSCT at 55° C; and twice in 0.2 x SSCT at 60° C for 30 min. Subsequently, the slices were detected 
using the peroxidase method with biotinylated donkey anti-mouse IgG antibodies and diaminobenzidine 
as chromogen (Vector Laboratories, Segrate, MI, Italy). The images of in situ hybridization were acquired 
using LSM510 Meta (Carl Zeiss, Germany) confocal microscope, and the maximal distance of 
hybridization signal in dendrites (maximal distance of dendritic labeling) was determined by AxionVision 
LE64 (Zeiss, Milano, Italy) using the function Measure Length. Dendrites of pyramidal neurons in CA1 and 
CA3 hippocampal regions have been analyzed; 3 rats for group and 2-3 slices for rat were analyzed. All 
the experiments were coded and analyzed in a blinded manner. 
 
2.6 Preparation of Protein Extracts and Western Blot Analyses  
Proteins were extracted as previously described (Caffino et al. 2018) with minor modifications. Briefly, 
Hip was homogenized in a teflon-glass potter in cold 0.32M sucrose buffer pH 7.4 containing 1 mM 
HEPES, 1 mM MgCl2⁠ 1 mM NaHCO3⁠ and 0.1 mM PMSF, in presence of commercial cocktail of protease 
(Roche, Monza, Italy) and phosphatase (Sigma-Aldrich, Milan, Italy) inhibitors and an aliquot of each 
homogenate was then sonicated. The remaining homogenate was centrifuged at 1000 g for 10 min 
obtaining a pellet (P1) corresponding to the nuclear fraction. The supernatant (S1) was then centrifuged 
at 9000g for 15 min to obtain a clarified fraction of cytosolic proteins (S2) and a pellet (P2). The pellet 
(P2), corresponding to a crude membrane fraction, was resuspended in a buffer containing 75mM KCl 
and 1% Triton X-100 and centrifuged at 100,000 x g for 1h. The resulting supernatant, referred as Triton 
X-100 soluble fraction (TSF), was stored at −20°C; the pellet, referred as postsynaptic density (PSD) or 
Triton X-100 insoluble fraction (TIF), was homogenized in a glass–glass potter in 20mM HEPES, protease 
and phosphatase inhibitors and stored at −20°C in presence of glycerol 30%. Total proteins have been 
measured in the total homogenate, in P1, S2 and TIF fractions according to the Bio-Rad Protein Assay, 
using bovine serum albumin as the calibration standard (Bio-Rad Laboratories, Segrate, Milan, Italy). 
Equal amount of proteins (10 ug) were run on criterion TGX precast gels (Bio-Rad Laboratories) under 
reducing conditions and electrophoretically transferred onto nitrocellulose membrane (Bio-Rad 
Laboratories). Blots were blocked 1 h at room temperature with I-Block solution (Life Technologies Italia, 
Italy) in TBS + 0.1% Tween-20 buffer, incubated with antibodies against the phosphorylated forms of the 
proteins and then stripped and reprobed with the antibodies against corresponding total proteins.  
The conditions of the primary antibodies were the following: anti mBDNF (1:500, Icosagen, 
Estonia); anti phospho-trkB Y706 (1:1000, Santa Cruz Biotechnology, USA); anti total trkB (1:750, Santa 
Cruz Biotechnology, USA); anti phospho-ERK2 T185/187 (1:1000, Cell Signaling Technology, USA); anti 
total ERK2 (1:5000, Cell Signaling Technology, USA); anti phospho-Akt S473 (1:1000, Cell Signaling 
Technology, USA); anti total Akt (1:1000, Cell Signaling Technology, USA); anti GR (1:500, 
ThermoScientific, USA). Results were standardized using β-actin as the control protein, which was 
detected by evaluating the band density at 43 kDa. Immunocomplexes were visualized by 
chemiluminescence using the Chemidoc MP Imaging System (Bio-Rad Laboratories) and analyzed using 
the Image Lab software from Bio-Rad. Gels were run 3 times each and the results represent the average 
from 3 different western blots. 
 
2.6 Analysis of plasma corticosterone and BDNF levels 
Samples of blood from each rat were collected in tubes containing EDTA (250 µL x 2 mL of blood 
collected) as anticoagulant agent. Plasma was separated by centrifugation (6500 g for 10 min). 
Corticosterone and BDNF levels were determined by an enzyme-linked immunosorbent assay (ELISA) 
using a commercial kit according to the manufacturers' instructions (Tecan, Italy; AbCam, UK, 
respectively). 
 
2.7 Statistical analysis 
Data were collected in individual animals (independent determinations) and are presented as 
means and standard errors. Behavioral and molecular changes produced by cocaine treatment during 
adolescence were analyzed by one-way analysis of variance (ANOVA) followed by Tukey’s test for 
multiple comparisons. Molecular changes of in situ hybridization produced by cocaine treatment during 
adolescence were analyzed by one-way analysis of variance (ANOVA) followed by Bonferroni’s multiple 
comparisons test. Behavioral and molecular changes produced by cocaine treatment during adulthood 
were analyzed by unpaired Student’s t-test. Pearson’s product-moment coefficients were calculated to 
study potential correlations between molecular and behavioral measurements in the pooled group of 
control, AN and NON-AN rats. Subjects were eliminated from the final dataset if their data deviated from 
the mean by 2 SDs. Prism 8.0 (GraphPad) was used to analyze all the data. Statistical significance was 
assumed at p<0.05.  
3. Results  
Seven days after a single injection of cocaine or saline during adolescence, rats were exposed to the 
sucrose preference test. Sucrose preference (F(2,33)=31.50, p<0.0001), shown in Fig.1a, allowed the 
identification of two separated populations of cocaine-exposed rats: those preferring water over sucrose 
(-46%, p=0.0013 vs saline) named anhedonic rats (from now on called AN rats) and those preferring 
sucrose over water (+44%, p=0.0035 vs saline; +90%, p<0.0001 vs AN), named non anhedonic rats 
(from now on called NON-AN rats). Importantly, the test was not influenced by the amount of water 
drunk by rats as both AN and NON-AN rats drank a similar amount of liquid (measured as the amount of 
water sucrose-free + water added with sucrose; F(2,33)=1.078, p=0.3521) (Fig. 1b), suggesting that the 
reduced sucrose intake in the AN group of rats is not linked to thirsty-related problems. 
In an attempt to find a potential mechanism to explain, at least partially, the difference between 
AN and NON-AN rats, we focused our attention on the neurotrophin BDNF, i.e. a molecule whose 
hippocampal regulation has been tightly linked to negative emotional states (Smith et al. 1995; 
Bjorkholm & Monteggia 2016). One-way ANOVA revealed that total Bdnf mRNA levels (F(2,22)=14.74, 
p<0.0001) were reduced in the hippocampus of AN rats (-31% vs saline, p=0.0494; -64% vs NON-AN, 
p<0.0001) while increased in the same brain region of NON-AN rats (+33% vs saline, p=0.0438) (Fig. 
2a). We next measured the expression of specific BDNF isoforms, Bdnf exon I, Bdnf exon IV, known to be 
activity-dependent and localized in the soma, and Bdnf exon VI, known to be targeted to dendrites 
(Chiaruttini et al. 2008). One-way ANOVA revealed a reduction of Bdnf exon I (F(2,24)=6.219, p=0.0067) 
and Bdnf exon IV mRNA levels (F(2,24)=8.279, p=0.0018) in the hippocampus of only AN rats (Bdnf exon 
I: -18% vs saline, p=0.0187; -18% vs NON-AN, p=0.0165; Bdnf exon IV: -16% vs saline, p=0.0017; -
11% vs NON-AN, p=0.0402). One-way ANOVA indicated a reduction of Bdnf exon VI mRNA levels 
(F(2,24)=4.579, p=0.0207; Fig 2d) both in AN (-14% vs saline, p=0.0362) and NON-AN rats (-15% vs 
saline, p=0.0297). As a further step of BDNF transcripts characterization, we performed in situ 
hybridization experiments (Figure 2g) to assess changes in Bdnf mRNA dendritic localization, since local 
translation and release of BDNF at synapses is likely dependent on dendritic transcripts. A moderate but 
significant decrease in the trafficking of total Bdnf mRNA was found in the CA3 region of hippocampus 
(F(2,631)=11.65, p<0.0001; Fig 2e) of both AN (-5.95µm vs saline, p=0.0003) and NON-AN (-5.9µm vs 
saline, p<0.0001). A similar pattern was found for Bdnf exon VI trafficking (F(2,788)=13.06, p<0.0001; 
AN: -5.18µm vs saline, p=0.0001; NON-AN: -5.81µm vs saline, p<0.001 Fig 2f), while Bdnf dendritic 
trafficking was only marginally affected in CA1 region of Hippocampus (total Bdnf: F(2,696)=3.022, p=0.05, 
Fig 2e; Bdnf exon VI: F(2,761)=3.568, p=0.0287, NON-AN: -2.1318µm vs saline, p=0.0328, Fig 2d). 
To determine whether changes in transcription paralleled changes in translation, we examined 
the expression of BDNF and its high affinity receptor trkB in the Hip homogenate and postsynaptic 
density (PSD), where synaptic transmission takes place, of cocaine-treated rats in comparison with 
saline-treated rats. These analyses are crucial to dissect the effect of adolescent cocaine exposure on 
BDNF protein translation, i.e. whole homogenate, from the availability of the neurotrophin at synaptic 
sites, i.e. PSD fraction. Figure 3a shows that the expression of the mature form of BDNF (mBDNF) was 
reduced in the homogenate of hippocampus (F(2,24)=18.24, p<0.0001) of AN rats (-14% vs saline, 
p=0.0496; -32% vs NON-AN, p<0.0001) while increased in the same brain region of NON-AN rats 
(+18%, p=0.0169). In the post-synaptic density, mBDNF levels (F(2,23)=6.091, p=0.0075; Fig 3b) were 
downregulated in the hippocampus of AN rats (-21% vs saline, p=0.0171; -19% vs NON-AN, p=0.0237) 
while unaltered in the same brain region of NON-AN rats (-2% vs saline, p=0.9689). We next measured 
the expression and activation of the BDNF high affinity receptor trkB (Fig. 3c, d). In the homogenate (Fig 
3c), we did not find any significant difference for both the phosphorylated form of trkB in Y706 
(F(2,22)=0.3075, p=0.7384) and trkB total levels (F(2,24)=1.142, p=0.3360). Conversely, in the 
postsynaptic density (Fig 3d), we found that the phosphorylation of trkB in Y706 (F(2,23)=10.51, 
p=0.0006) was significantly reduced in the hippocampus of AN (-29% vs saline, p=0.0054; -33% vs 
NON-AN, p=0.0009) whereas no changes were observed in the same brain region of NON-AN rats (+4% 
vs saline, p=0.9033). Similarly, trkB protein levels (F(2,24)=6.582, p=0.0053) were reduced in the 
hippocampus of AN (-26% vs. saline, p=0.0073; -19% vs. NON-AN, p=0.0346) but not in the same brain 
region of NON-AN rats (-7% vs. saline, p=0.6864).  
Next, we examined the main BDNF-dependent intracellular pathways, i.e. Akt and Erk2, in the 
homogenate of AN and NON-AN rats. The analysis of the ratio pAkt S473/Akt (F(2,23)=11.37, p=0.0004) 
revealed a reduction in AN rats (-20% vs. saline, p=0.0357; -33% vs. NON-AN, p=0.0003) with no 
changes in NON-AN rats (+13% vs. saline, p=0.2254) (Fig. 4a). Similarly, the analysis of the ratio pErk2 
T185/187/Erk2 (F(2,24)=9.947, p=0.0007) showed a reduction in AN rats (-29% vs. saline, p=0.0023; -26% 
vs. NON-AN, p=0.0031) with no changes in NON-AN rats (-3% vs. saline, p=0.9311) (Fig. 4b).  
To investigate the potential relationship between sucrose preference and mBDNF levels we 
performed a Pearson’s product–moment correlation analysis. As shown in Figure 5, Pearson’s correlation 
analysis revealed that sucrose preference correlates positively with mBDNF levels in both homogenate 
(r=0.5953, p=0.0011, Fig. 5a) and post-synaptic density (r=0.4340, p=0.0267, Fig. 5b). 
We next measured the levels of the neurotrophin in the plasma as it has been previously 
observed that plasma BDNF levels are reduced during negative emotional states in humans (Lee et al. 
2007). One-way ANOVA revealed that BDNF levels (F(2,24)=5.468, p=0.011) are significantly reduced in 
the plasma of AN (-345 pg/µl vs. saline, p=0.008), but not NON-AN (-216 pg/µl vs. saline, p=0.1387), 
rats (Fig. 6). 
The following step was to measure glucocorticoid release in the two subpopulations of rats, as the 
hypothalamic-pituitary adrenal (HPA) axis has been shown to be dysfunctional during negative emotional 
states (Zorn et al. 2017). We found increased corticosterone levels in the plasma of AN rats 
(F(2,23)=9.551, p=0.001; +3.89 ng/ml vs saline, p=0.0267; +5.62 ng/ml vs NON-AN, p=0.001) with no 
significant variations from control levels in NON-AN rats (-1.73 ng/ml vs saline, p=0.4869) (Fig. 7a). Of 
note, Pearson’s correlation analysis revealed that sucrose preference negatively correlates with 
circulating corticosterone levels (r=-0.6311, p=0.0013, Fig. 7b). It is widely established that 
corticosterone binds to glucocorticoid receptors (GR) that, by moving into the nucleus, regulate the 
expression of downstream genes through the binding to DNA response elements (de Kloet et al. 2005). 
Thus, we measured the ratio between GR expression in the nucleus and cytoplasm, an index of GR 
translocation into the nucleus. We found a significant reduction of such ratio in both AN (F(2,24)=23.89, 
p<0.0001; -46% vs saline, p<0.0001) and NON-AN (-21% vs saline, p=0.0193) rats when compared to 
saline-treated rats; however, the reduction was significantly lower in AN rats when compared to NON-N 
rats (-25% vs NON-AN, p=0.0014, Fig. 7c).  
In order to investigate whether the behavioural and molecular changes above shown are peculiar 
of adolescence or, instead, common to adulthood, we exposed adult rats to the same treatment and 
analysed the same behavioural and molecular parameters. The sucrose preference test revealed that all 
rats preferred the sucrose solution (Fig. 8a). Adult rats exposed to a single injection of cocaine exhibited 
increased levels of mBDNF (+21%, t(16)=2.787, p=0.0132, Fig. 8b), enhanced phosphorylation and 
expression of trkB (ptrkB: +22%, t(16)=2.299, p=0.0353; trkB: +19%, t(16)=3.203, p=0.0055; Fig. 8c) 
whereas no changes were observed for the ratio pAkt S473/Akt and pErk2 T185/187/Erk2 (data not shown). 
Peripheral analyses revealed that a single injection of cocaine up-regulated BDNF expression in the 
plasma of adult rats (+504 pg/µl, t(16)=2.841, p=0.0118; Fig. 8d) while reducing corticosterone plasma 
levels (-7.35 ng/ml, t(16)=2.245, p=0.0392; Fig. 8e). 
 
 
 
 
4. Discussion 
 
Our findings show that a single injection of cocaine during adolescence identifies two separated, 
emotionally distinct subpopulations of rats in response to the sucrose preference test, i.e. anhedonic (AN) 
and non-anhedonic (NON-AN) rats. Such clustering is accompanied by a different modulation of the 
neurotrophin BDNF at both central and peripheral level. 
Anhedonia has been critically associated to abstinence in humans (Garfield et al. 2017; Gawin & 
Kleber 1986) and withdrawal in rodents (Markou & Koob 1991; Scheggi et al. 2011) following repeated 
exposure to drugs of abuse. Our results represent the first evidence that a single exposure to cocaine 
during adolescence is sufficient to shape an anhedonic phenotype in rats, rewriting the standard view 
that prolonged exposure to drugs of abuse is necessary to cause depressive-like symptoms. Indeed, 
albeit occurring after a single cocaine injection, such effects are far from being simply acute as they last, 
at least, for a week. Of note, the lack of an anhedonic-like behaviour in adult rats exposed to the same 
treatment bolsters the notion that the adolescent brain is uniquely receptive to the emotional effects 
caused by a single cocaine exposure.  
Vulnerability or resiliency to anhedonia following a single cocaine exposure during adolescence 
seems to depend upon the modulation of BDNF, both at central and peripheral level. In the homogenate 
of hippocampus of adolescent AN rats, we found a significant reduction of Bdnf mRNA and protein levels, 
of the high affinity receptor trkB as well as of major BDNF-mediate intracellular pathways, such as Akt 
and ERK2. Notably, in adolescent AN rats, BDNF expression was reduced also at the synaptic level. 
Intriguingly, adolescent AN rats show reduced BDNF plasma levels as well. The evidence that we found a 
significant association between reduced BDNF protein levels (both in the homogenate and in the post-
synaptic density) and the anhedonic behaviour fosters the possibility that a decrease of hippocampal 
BDNF signalling may contribute to the anhedonic phenotype, an effect that may be strengthened by the 
reduced peripheral levels of the neurotrophin. Of note, the contribution of reduced BDNF levels to an 
anhedonic phenotype has been recently suggested by Martin and associates in an elegant paper 
employing BDNF heterozygous mice (Martis et al. 2019). Additionally, we also found reduced mRNA 
trafficking at dendrites in AN rats suggesting both reduced trafficking and local protein synthesis of the 
neurotrophin. Thus, it appears that vulnerability to AN critically depends upon reduced BDNF synaptic 
levels, perhaps lowering the threshold to develop anhedonic behaviour. Conversely, in NON-AN rats, 
BDNF expression is increased in the whole homogenate, leading to a stabilization of its downstream 
signalling, unaltered in the synaptic fraction and reduced as mRNA transport raising the possibility that 
NON-AN rats compensate the reduced trafficking of Bdnf mRNA by up-regulating the protein levels of the 
neurotrophin: it is suggested that their resiliency to AN relies on their ability to create an hippocampal 
reservoir of the neurotrophin to be used in case of demand (Taliaz et al. 2011). Strikingly, this is in line 
with recent evidence showing higher mBDNF levels in the hippocampus of rats resilient to chronic mild 
stress (Tornese et al. 2019) suggesting that the elevation of the hippocampal expression of this 
neurotrophin may be considered a reliable marker of resiliency that may be independent from the 
experimental context. Under our experimental conditions, such resiliency may be corroborated by the 
evidence that BDNF levels in the plasma of NON-AN adolescent rats are maintained at control levels. 
Intriguingly, 7 days after a single injection of cocaine, AN rats exhibited significantly higher levels 
of circulating glucocorticoids compared to controls at variance from NON AN rats whose glucocorticoid 
levels were unaltered. Our results recapitulate the elevation of glucocorticoid release previously found in 
cocaine-withdrawn rats (Zhou et al. 2011; Georgiou et al. 2016) and abstinent cocaine users (Gawin & 
Kleber 1985; Kalechstein et al. 2002; Contoreggi et al. 2003; Morie et al. 2014) thus supporting the 
translational validity of these findings and further pointing to adolescence as a critical period of high 
vulnerability since it exacerbates the effect of a single exposure to cocaine. We hypothesize that the 
markedly reduced nuclear translocation of GR in AN rats, at variance from the attenuated decline 
observed in NON-AN rats, tones down the natural feedback on the HPA axis, thus representing a 
mechanism to explain the elevation of corticosterone levels observed in AN rats. 
 In order to investigate whether the emotional response to a single injection of cocaine was 
restricted to adolescence or, instead, common to adulthood, we exposed adult rats to the same 
experimental paradigm. We found that adult rats showed preference to sucrose. Further, we found 
increased expression of mBDNF and trkB in the hippocampus of adult rats as well as higher BDNF levels 
and reduced corticosterone levels in their plasma. These results indicate that adult rats are not 
vulnerable to the effects of the single dose of cocaine, presumably via their ability to keep stable levels of 
the neurotrophin both in hippocampus and plasma, stressing the notion that resilience cannot be merely 
interpreted as reversal of vulnerability. 
We are aware that our study holds some limitations. For instance, we analyzed the whole 
hippocampus without differentiating between dorsal and ventral sub-regions: however, to the best of our 
knowledge, there is no evidence about a different role played by these two sub-regions in the modulation 
of anhedonic-like behaviors following cocaine exposure. In addition, given the within-subject design type 
of study, we could measure brain and plasma BDNF concentration only at the end of the study, i.e. 7 
days after the single injection: this does not inform us about the time of onset of both the behavioural 
and molecular changes while instructing, however, on the long-lasting nature of such alterations. 
 
5. Conclusions 
In conclusion, AN rats exhibit reduced hippocampal BDNF signalling together with a decline of plasma 
BDNF expression and increased corticosterone plasma levels thus recapitulating a clinical, depression-like 
endophenotype. Conversely, the resilience to AN shown by NON-AN rats appears to be due, at least in 
part, to increased hippocampal BDNF signalling together with stabilized BDNF downstream signaling and 
corticosterone plasma levels. This resilient feature is shared by adult rats that do not exhibit signs of 
anhedonia, up-regulate BDNF and trkB expression and stabilize the neurotrophin downstream signalling. 
These data also reveal BDNF as a versatile and finely-tuned molecule with unique properties in the effects 
caused by different drugs of abuse, in line with our previous data showing that an opposite modulation of 
BDNF can dissect the antidepressant from the reinforcing properties of ketamine (Caffino et al. 2016).  
Since anhedonia represents a core feature of addiction (Tang et al., 2015), further studies are 
needed to evaluate whether AN/NON-AN adolescent rats show different proneness to substance use later 
in life in order to identify the underlying mechanisms. This issue is of critical importance since an 
association between anhedonia and marijuana use escalation across mid-adolescence in humans has 
been demonstrated (Leventhal et al. 2017). Since symptoms of anhedonia have been found to be 
associated with relatively poor outcomes of treatment response (Crits-Christoph et al. 2018), our findings 
suggest that first exposure to cocaine during adolescence might have profound consequences, however 
often overlooked.  
 
Acknowledgement 
This research was supported by grants from the Dipartimento delle Politiche Antidroga (Rome, Italy), 
through the ERANID Grant “STANDUP” awarded to FF as well as by grants from MIUR Progetto 
Eccellenza. 
 
Declaration of Interest 
None. 
 
Author’s contribution 
LC and FM performed the animal studies. LC and FM performed the molecular analyses. JM and AB 
performed the in situ hybridization experiments. LC and FM did the statistical analyses. LC, FM and JM 
managed the literature searches. LC, GZ, AB and FF designed the study and wrote the protocol. LC, GZ, 
AB and FF interpreted the data and wrote the manuscript. All authors contributed to and have approved 
the final manuscript.  
 
Figure legends 
Fig 1 Effect of a single injection of cocaine during adolescence on sucrose preference test. Male 
rats were exposed to a single injection of saline or cocaine (20 mg/kg) at postnatal day 35 (PND 35) and 
7 days later, i.e. at PND 42, sucrose preference test was performed. Sucrose preference was calculated 
as sucrose intake(g)/total fluid (sucrose + water) intake (g) X 100 and data are presented in panel (a). 
In panel (b), total liquid intake, calculated as sucrose + water intake (g), is shown. 
Bar graphs represent the mean ± SEM from at least seven independent determinations. *p<0.05 vs 
saline-treated rats; $$$p<0.001 vs NON-Anhedonic rats (one-way ANOVA followed by Tukey’s multiple 
comparisons test). 
 
Fig 2 Effect of a single injection of cocaine during adolescence on Bdnf mRNA levels in the 
hippocampus (Hip). 
The data represent the mRNA levels for total Bdnf (a), Bdnf exon I (b), Bdnf exon IV (c) and Bdnf exon 
VI (d) in the whole hippocampus expressed as a percentage of saline-treated rats. In panel (e) and (f), 
total Bdnf and Bdnf exon VI mRNA trafficking are shown in the CA1 (left) and CA3 (right) subregions of 
the hippocampus. Panel (g) shows representative images of in situ hybridization of total Bdnf mRNA 
levels in CA1 and CA3 regions of hippocampus. 
Bar graphs represent the mean ± SEM from at least seven independent determinations. *p<0.05, 
**p<0.01 and ***p<0.001 vs saline-treated rats; $p<0.05 and $$$p<0.001 vs NON-Anhedonic rats (one-
way ANOVA followed by Tukey’s multiple comparisons test). 
 
Fig 3 Effect of a single injection of cocaine during adolescence on mBDNF and trkB protein 
levels in the whole homogenate (Homo) and in the post-synaptic density (PSD) of rat Hip. 
Panel (a) and (b) show mBDNF protein levels in the Homo and PSD of Hip (respectively). Panel c and d 
show the phosphorylation in Tyr706 (left side) and the total form (right side) of the trkB receptor in the 
Homo and PSD of Hip (respectively). In the upper panel, representative immunoblots are shown for 
mBDNF (14 kDa), ptrkB Y706 (145 kDa), trkB (145 kDa) and b-Actin (43 kDa) proteins in the 
homogenate and post-synaptic density of hippocampus. 
Histograms, expressed as percentages of saline-treated rats, represent the mean ± SEM of at least seven 
rats per group. *p<0.05 and **p<0.01 vs saline-treated rats; $p<0.05, $$p<0.01, $$$p<0.001 vs NON-
Anhedonic rats (one-way ANOVA followed by Tukey’s multiple comparisons test). 
S=saline; A=Anhedonic; N-An=NON-Anhedonic 
Fig 4 Effect of a single injection of cocaine during adolescence on BDNF-downstream signalling 
in the Homo of rat Hip. 
Panel (a) and panel (b) show the activation of Akt and ERK2, respectively, both expressed as the ratio 
between the phosphorylated and the total form of the protein. Below the graphs, representative 
immunoblots are shown for pAkt Ser473 (60 kDa), Akt (60 kDa), pERK2 Thr185-Tyr187 (42 kDa) and 
ERK2 (42 kDa) proteins in the whole homogenate of hippocampus.  
Histograms, expressed as percentages of saline-treated rats, represent the mean ± SEM of at least seven 
rats per group. *p<0.05 and **p<0.01 vs saline-treated rats; $$p<0.01, $$$p<0.001 vs NON-Anhedonic 
rats (one-way ANOVA followed by Tukey’s multiple comparisons test). 
S=saline; A=Anhedonic; N-An=NON-Anhedonic 
 
Fig 5 Pearson’s product–moment correlation(r) analyses between mBDNF protein levels and sucrose 
preference in homogenate (panel a) and post-synaptic density (panel b) of hippocampus of rats exposed 
to a single injection of cocaine during adolescence. 
  
Fig 6 Effect of a single injection of cocaine during adolescence on BDNF plasma levels. 
Histograms, expressed as picogram per milliliter, represent the mean ± SEM of at least seven rats per 
group. *p<0.05 vs saline-treated rats (one-way ANOVA followed by Tukey’s multiple comparisons test). 
 
Fig 7 Effect of a single injection of cocaine during adolescence on hypotalamus-pituitary-
adrenal axis (HPA) activity. 
Panel (a) shows the levels of corticosterone, expressed as nanogram per milliliter, in the plasma of AN 
and NON-AN rats. Panel (b) shows Pearson’s product–moment correlation (r) analyses between 
corticosterone plasma levels and sucrose preference. Panel (c) shows the ratio between nuclear and 
cytosolic glucocorticoid receptor (GR) protein levels in the hippocampus of rats exposed to a single 
injection of cocaine during adolescence. Below the graph, representative immunoblots are shown for GR 
(95 kDa) protein in the nucleus and cytosol of hippocampus.  
Histograms, expressed as percentages of saline-treated rats in panel C, represent the mean ± SEM of at 
least seven rats per group. *p<0.05 and ***p<0.001 vs saline-treated rats; $$p<0.01, $$$p<0.001 vs 
NON-Anhedonic rats (one-way ANOVA followed by Tukey’s multiple comparisons test). 
S=saline; A=Anhedonic; N-An=NON-Anhedonic 
 
 
 Fig 8 Effect of a single injection of cocaine during adulthood on sucrose preference and on 
BDNF-downstream signalling in the rat hippocampus. 
Panel (a) shows sucrose preference measured seven days after a single cocaine injection during 
adulthood. Panel (b) and (c) show mBDNF protein levels and the phosphorylation in Tyr706 (left side) 
and the total form (right side) of the trkB receptor in the whole homogenate of hippocampus 
(respectively). In panel (f), representative immunoblots are shown for mBDNF (14 kDa), ptrkB Y706 (145 
kDa), trkB (145 kDa) and b-Actin (43 kDa) proteins in the whole homogenate of hippocampus. Panel (d) 
and (e) shows the levels of BDNF, expressed as picogram per milliliter, and corticosterone, expressed as 
nanogram per milliliter, in the plasma of AN and NON-AN rats (respectively). 
Histograms, expressed as percentages of saline-treated rats in panel (b) and (c), represent the mean ± 
SEM of at least seven rats per group. *p<0.05 and **p<0.01 vs saline-treated rats (unpaired Student’s t 
test). 
S=saline; C=cocaine 
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